HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shingo Miyamoto Selected Research

Azoxymethane

8/2017Anticarcinogenic Effects of Dried Citrus Peel in Colon Carcinogenesis Due to Inhibition of Oxidative Stress.
8/2016Effects of Walnut Consumption on Colon Carcinogenesis and Microbial Community Structure.
11/2015Suppressive effects of the NADPH oxidase inhibitor apocynin on intestinal tumorigenesis in obese KK-A(y) and Apc mutant Min mice.
10/2013Suppression of colon carcinogenesis by targeting Notch signaling.
8/2011Selective PGE(2) suppression inhibits colon carcinogenesis and modifies local mucosal immunity.
1/2010Increased visceral fat mass and insulin signaling in colitis-related colon carcinogenesis model mice.
1/2009Zerumbone, a tropical ginger sesquiterpene, inhibits colon and lung carcinogenesis in mice.
9/2008Aqueous and ethanolic extract fractions from the Brazilian propolis suppress azoxymethane-induced aberrant crypt foci in rats.
9/2008A tobacco-specific carcinogen, NNK, enhances AOM/DSS-induced colon carcinogenesis in male A/J mice.
5/2008Suppressive effects of nobiletin on hyperleptinemia and colitis-related colon carcinogenesis in male ICR mice.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shingo Miyamoto Research Topics

Disease

84Neoplasms (Cancer)
01/2022 - 12/2002
28Carcinogenesis
01/2020 - 03/2003
25Ovarian Neoplasms (Ovarian Cancer)
07/2018 - 03/2003
18Colonic Neoplasms (Colon Cancer)
03/2022 - 04/2007
12Colorectal Neoplasms (Colorectal Cancer)
02/2021 - 08/2011
11Inflammation (Inflammations)
02/2021 - 05/2007
9Intestinal Polyps
03/2022 - 07/2015
9Neoplasm Metastasis (Metastasis)
07/2018 - 05/2006
9Aberrant Crypt Foci
08/2017 - 05/2006
8Polyps
03/2022 - 08/2010
8Carcinoma (Carcinomatosis)
01/2022 - 12/2002
8Lung Neoplasms (Lung Cancer)
04/2021 - 01/2008
8Colitis
03/2013 - 04/2007
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2021 - 12/2016
7Body Weight (Weight, Body)
06/2012 - 05/2006
6Uterine Cervical Neoplasms (Cancer of the Cervix)
12/2021 - 06/2005
5Breast Neoplasms (Breast Cancer)
10/2013 - 01/2008
4Adenocarcinoma
01/2009 - 08/2007
3Chorioamnionitis
10/2021 - 01/2019
3Infections
10/2021 - 06/2012
3Endometrial Neoplasms (Endometrial Cancer)
08/2019 - 07/2016
3Adenoma (Adenomas)
07/2018 - 10/2012
3Triple Negative Breast Neoplasms
07/2016 - 12/2010
3Obesity
01/2016 - 01/2010
3Hemorrhage
09/2014 - 10/2010
3Ascites
06/2012 - 08/2004
2Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
03/2022 - 01/2019
2Fibrosis (Cirrhosis)
01/2022 - 01/2020
2Hypoxia (Hypoxemia)
01/2022 - 05/2013
2Disease Progression
01/2020 - 02/2019
2Chronic Disease (Chronic Diseases)
03/2019 - 06/2012
2Ovarian Epithelial Carcinoma
07/2018 - 07/2009
2Adenocarcinoma of Lung
06/2018 - 10/2010
2Renal Cell Carcinoma (Grawitz Tumor)
06/2018 - 01/2008
2Sarcoma (Soft Tissue Sarcoma)
06/2018 - 02/2011

Drug/Important Bio-Agent (IBA)

29Heparin-binding EGF-like Growth Factor (HB-EGF)IBA
07/2018 - 08/2004
21Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
07/2018 - 08/2004
20Epidermal Growth Factor (EGF)IBA
07/2018 - 07/2005
19Heparin (Liquaemin)FDA LinkGeneric
07/2018 - 07/2005
17AzoxymethaneIBA
08/2017 - 05/2006
14ErbB Receptors (EGF Receptor)IBA
11/2021 - 08/2004
14Biomarkers (Surrogate Marker)IBA
10/2021 - 12/2006
13CRM197 (non-toxic variant of diphtheria toxin)IBA
01/2017 - 08/2004
12LigandsIBA
07/2018 - 07/2005
9Messenger RNA (mRNA)IBA
04/2020 - 12/2002
8Antineoplastic Agents (Antineoplastics)IBA
07/2018 - 10/2008
8Biological ProductsIBA
07/2015 - 10/2004
6Proteins (Proteins, Gene)FDA Link
07/2017 - 08/2004
6Dextran SulfateIBA
03/2013 - 05/2008
6AntigensIBA
07/2010 - 06/2005
5MicroRNAs (MicroRNA)IBA
10/2021 - 06/2012
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2020 - 03/2003
5Paclitaxel (Taxol)FDA LinkGeneric
05/2017 - 03/2009
5Irinotecan (Camptosar)FDA LinkGeneric
02/2016 - 09/2010
5Drinking WaterIBA
01/2009 - 02/2007
4Interleukin-6 (Interleukin 6)IBA
10/2021 - 04/2017
4Immune Checkpoint InhibitorsIBA
01/2021 - 02/2019
4Proliferating Cell Nuclear Antigen (PCNA)IBA
01/2020 - 04/2007
4Reactive Oxygen Species (Oxygen Radicals)IBA
01/2020 - 01/2010
4Tyrosine Kinase InhibitorsIBA
01/2020 - 03/2009
4DNA (Deoxyribonucleic Acid)IBA
01/2018 - 05/2007
4Cisplatin (Platino)FDA LinkGeneric
05/2017 - 11/2010
4Bevacizumab (Avastin)FDA Link
12/2016 - 07/2011
4Phosphotransferases (Kinase)IBA
08/2015 - 08/2004
4AmphiregulinIBA
04/2015 - 01/2008
4Dextrans (Dextran)FDA Link
01/2008 - 05/2007
4sodium sulfate (sodium bisulfate)FDA LinkGeneric
01/2008 - 05/2007
3CytokinesIBA
01/2022 - 01/2010
3PlatinumIBA
08/2019 - 08/2015
3Pharmaceutical PreparationsIBA
01/2019 - 05/2017
3Matrix Metalloproteinase 14 (MT1-MMP)IBA
07/2018 - 01/2011
3Transcription Factor AP-1 (Transcription Factor AP 1)IBA
08/2017 - 06/2012
3Metalloproteases (Metalloproteinases)IBA
08/2015 - 07/2005
3CarcinogensIBA
08/2011 - 09/2008
3ProstaglandinsIBA
08/2011 - 03/2007
3beta CateninIBA
01/2010 - 01/2007
3VimentinIBA
07/2009 - 10/2005
3lysophosphatidic acidIBA
07/2005 - 03/2003
2Cyclooxygenase 2 (Cyclooxygenase-2)IBA
03/2022 - 05/2017
2Cyclin D1IBA
03/2022 - 04/2017
2Adenosine Triphosphate (ATP)IBA
01/2022 - 12/2002
2InterleukinsIBA
10/2021 - 04/2020
2Anti-Bacterial Agents (Antibiotics)IBA
10/2021 - 05/2017
2Ribosomal DNA (rDNA)IBA
10/2021 - 02/2021
2CurcuminIBA
04/2020 - 03/2013
2taxaneIBA
08/2019 - 08/2015
2NivolumabIBA
02/2019 - 06/2018
2fucoxanthinolIBA
01/2019 - 07/2017
2NF-kappa B (NF-kB)IBA
01/2019 - 06/2012
2Glucose (Dextrose)FDA LinkGeneric
01/2019 - 07/2013
2Indicators and Reagents (Reagents)IBA
07/2018 - 06/2012
2LipidsIBA
07/2017 - 08/2011
2CateninsIBA
04/2017 - 07/2015

Therapy/Procedure

39Therapeutics
03/2019 - 08/2004
19Drug Therapy (Chemotherapy)
04/2020 - 05/2006
7Radiotherapy
02/2019 - 12/2008
5Chemoprevention
01/2016 - 01/2007
3Intravenous Administration
01/2017 - 10/2013
3Subcutaneous Injections
01/2007 - 05/2006
2Hysterectomy
12/2021 - 06/2013